AKAM vs BRNS · P/E 27, rev $2.17B vs $38.2M cap
Akamai Technologies Inc (AKAM) versus Barinthus Biotherapeutics plc (BRNS) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. BRNS currently screens at market cap $38.2M.
Not investment advice. Open the AKAM and BRNS stock pages for the full models.
Not investment advice.